Bluestein Sanfurd 4
4 · LABARGE INC · Filed Dec 28, 2004
Insider Transaction Report
Form 4
Bluestein Sanfurd
10% Owner
Transactions
- Purchase
Common Stock
2004-05-19$7.25/sh+2,700$19,571→ 935,300 total - Purchase
Common Stock
2004-05-24$6.90/sh+1,800$12,420→ 940,300 total - Purchase
Common Stock
2004-05-10$7.12/sh+15,000$106,730→ 941,400 total - Sale
Common Stock
2004-05-12$7.25/sh−6,100$44,225→ 935,300 total - Purchase
Common Stock
2004-05-14$7.36/sh+5,000$36,800→ 935,300 total - Purchase
Common Stock
2004-05-04$7.82/sh+5,000$39,100→ 891,400 total - Purchase
Common Stock
2004-05-11$7.33/sh+3,200$23,468→ 941,400 total - Purchase
Common Stock
2004-05-12$7.25/sh+6,800$49,324→ 941,400 total - Purchase
Common Stock
2004-05-05$7.80/sh+20,000$156,100→ 911,400 total - Purchase
Common Stock
2004-05-26$7.20/sh+3,200$23,040→ 940,300 total - Purchase
Common Stock
2004-05-03$8.00/sh+5,000$40,000→ 891,400 total - Purchase
Common Stock
2004-05-21$6.85/sh+5,000$34,250→ 940,300 total - Purchase
Common Stock
2004-05-07$7.30/sh+5,000$36,500→ 926,400 total - Purchase
Common Stock
2004-05-20$7.40/sh+2,300$17,020→ 935,300 total - Purchase
Common Stock
2004-05-06$7.40/sh+10,000$74,000→ 921,400 total
Holdings
- 185,000(indirect: See Note 1)
Common Stock
- 160,000(indirect: See Note 1)
Common Stock
- 170,000(indirect: See Note 1)
Common Stock
- 181,800(indirect: See Note 1)
Common Stock
- 177,700(indirect: See Note 1)
Common Stock
- 163,200(indirect: See Note 1)
Common Stock
- 175,000(indirect: See Note 1)
Common Stock
- 180,000(indirect: See Note 1)
Common Stock
- 155,000(indirect: See Note 1)
Common Stock
Footnotes (1)
- [F1]All shares of La Barge, Inc. common stock listed as indirectly owned by the reporting person are owned by Dr. Bluestein himself, as a controlling member of the general partner, and a limited partner, of Bluestein Family Partnership, L.P. Dr. Bluestein has elected to report the entire amount of the Bluestein Family Partnership, L.P.'s interest in the securities of the issuer, pursuant to Instruction 4(b)((iv) of this Form; however, Dr. Bluestein owns a 50% interest in said Partnership.